Poland, April 30 -- Poland based Abbvie Sp. z o.o. has secured contract from Centrum Onkologii im. Franciszka Lukaszczyka w Bydgoszczy for Antineoplastic agents Delivery of medicinal products - Mirvetuximab Soravtansine. The value of the contract is worth 3849997800 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....